FASEB J. FASEB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
fj.08-108894v1
fj.08-108894v2
fj.08-108894v3
22/10/3537    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vukojevic, V.
Right arrow Articles by Terenius, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vukojevic, V.
Right arrow Articles by Terenius, L.
Published online before print July 24, 2008 as doi: 10.1096/fj.08-108894.

µ-Opioid receptor activation in live cells

Vladana Vukojevic, Yu Ming, Claudio D'Addario, Mats Hansen, Ülo Langel, Rüdiger Schulz, Björn Johansson, Rudolf Rigler, and Lars Terenius

E-mail contact: vladana.vukojevic@ki.se

Interaction of the µ-opioid receptor (MOP) with selected ligands was investigated in live cells using advanced imaging by confocal laser scanning microscopy integrated with fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy. In PC12 cells stably transformed to express the fluorescently labeled MOP-enhanced green fluorescent protein construct, two pools of MOP were identified that could be discriminated by differences in their lateral mobility in the cell membrane. The majority of MOP receptors (80±10%) were characterized by a diffusion coefficient DMOP, 1 = (4±2) x 10-11 m2 s-1, compared with the slowly moving fraction, DMOP, 2 = (4±2) x 10-12 m2 s-1. On stimulation with selected agonists ([D-Ala2,N-MePhe4,Gly-ol5]enkephalin, enkephalin-heptapeptide Tyr-Gly-Gly-Phe-Met-Arg-Phe, morphine, and methadone), surface density of the MOP decreased, whereas the lateral mobility increased. In contrast, antagonists (naloxone and naltrexone) "froze" the receptor in the membrane, i.e., increased MOP surface density and decreased lateral mobility. Agonist activation was also accompanied by pronounced changes in the dynamics of plasma membrane lipids, as revealed by the general lipid marker 1,1`-dioctadecyl-3,3,3`,3`-tetramethylindocarbocyanine perchlorate dye. The results provide new information about MOP activation in live cells at the molecular level, with a special focus on the dynamics of the intricate interplay between this receptor and the surrounding lipids.—Vukojevic, V., Ming, Y., D'Addario, C., Hansen, M., Langel, Ü., Schulz, R., Johansson, B., Rigler, R., Terenius, L. µ-Opioid receptor activation in live cells.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by The Federation of American Societies for Experimental Biology.